ARCHIVES

NSABP Breast Cancer Prevention Trial Reports Final Results On Tamoxifen

This article is from The Cancer Letter archive.

Vol. 28 No. 11 | November 25, 2005

Download PDF Visit The Full Archive

Related Articles

Gleevec Approval Sets Record For FDA Review: 73 Days

May 25, 2001

FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications

September 4, 2009

Committee Drafts QRA Definition

November 19, 1982

RFP Suggestions For Immunodiagnosis Research Offered

October 22, 1976

NCI To Fund 160 P01s FY91, About same As Last Year; Considering New ‘Interactive’ R01

June 21, 1991

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002